Danish biotech company wins orphan drug designation
The FDA has granted orphan drug designation to the most advanced candidate from a Danish biotech company.
BY BENJAMIN WERNER CHRISTENSEN
The Danish biotech company Orphazyme has gone from strength to strength in recent months and now there is another feather in the company’s cap.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Danish biotech bags EUR 20 million
For abonnenter
Randi Krogsgaard leaves Dansk Biotek
For abonnenter
Here is why Topotarget Chairman stepped back
For abonnenter
